Analyse @AlbertBourla's tweets
I’m pleased to share that we have received Emergency Use Authorization from the @US_FDA for our Omicron BA.4/BA.5-adapted #COVID19 vaccine for children aged 5-11. This is an important milestone as we head into the winter months ahead: on.pfizer.com/3MtRKW2